Last updated: August 17, 2026

Hematopoietic Progenitor Cells: The Origin of Blood Cells

Hematopoietic progenitor cells (HPCs) are the foundation of the blood system, giving rise to all the different types of blood cells, including red blood cells, white blood cells, and platelets. These cells are found in the bone marrow and are responsible for maintaining a constant supply of new blood cells throughout life.

From Pluripotency to Lineage Commitment

HPCs are pluripotent, meaning they have the potential to develop into any type of blood cell. As they mature, they undergo a process of lineage commitment, in which they become restricted to a particular lineage, such as the myeloid lineage (which gives rise to red blood cells, white blood cells, and platelets) or the lymphoid lineage (which gives rise to lymphocytes).

Regulation of Hematopoiesis

The production of HPCs and their differentiation into mature blood cells is a tightly regulated process. A variety of factors, including growth factors, cytokines, and cell-cell interactions, play a role in controlling hematopoiesis. These factors ensure that the right number and type of blood cells are produced to meet the needs of the body.

Clinical Applications

HPCs have important clinical applications in the treatment of blood disorders, such as leukemia and lymphoma. In bone marrow transplantation, HPCs from a healthy donor are transplanted into a patient with a diseased bone marrow. These HPCs then repopulate the patient’s bone marrow and produce healthy blood cells. HPCs are also used in gene therapy to treat genetic blood disorders, such as sickle cell disease and thalassemia.

HPCs are essential for maintaining a healthy blood system. Their ability to self-renew and differentiate into different types of blood cells is a remarkable example of the body’s regenerative capacity. Understanding the biology of HPCs is critical for developing new treatments for blood disorders and other diseases.

Scientific case review

Scientific Case Review

Would you like to understand whether current clinical programs, recent research developments, or emerging approaches may be relevant to your individual situation?

Share your question with our scientific research team and receive information focused on the areas of current research that may be relevant to your case.

  • Review of the information you provide
  • Relevant research and clinical program information
  • A clear response focused on your situation
What happens next? Send your question, receive a focused scientific review, and get a clear response about research and clinical programs relevant to your situation.
Your scientific review will be prepared by Dr. Helen Melnik, PhD , who has more than 25 years of experience in stem cell research and international clinical programs.

No obligation. Your question will be reviewed confidentially.

Educational and research information only. This service does not constitute medical advice, diagnosis, prescription, or a personalized treatment recommendation.

Categories: Stem cell in Europestem cell researchstem cell therapiesStem Cell therapyStem Cell Therapy & Clinical ResearchStem Cell Treatmentstem cellsstem cells therapystem cells treatment

NBScience

contract research organization

WhatsApp